Novo Nordisk A/S
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. […]
Read More
European markets open lower; Novo Nordisk, Novartis retreat
European markets opened lower on Tuesday as global markets buckle amid anxiety that the U.S. economy will suffer because of President Donald Trump’s trade tariff policies. The pan-European Stoxx 600 index was around 0.2% lower shortly after the opening bell, with the U.K.’s FTSE 100 down 0.2%, while France’s CAC 40 was up 0.3%, and […]
Read More
Stocks making the biggest moves midday: Tesla, Robinhood, Nvidia, Cognizant and more
Check out the companies making headlines in midday trading: Bank stocks — Major banks came under pressure during Monday’s session amid rising concerns about a potential slowdown in the U.S. economy. JPMorgan Chase and Goldman Sachs fell roughly 4%. Citigroup slid more than 4%, and Wells Fargo dropped 5%. Bank of America shed more than […]
Read More
Stocks making the biggest moves premarket: JPMorgan Chase, Coinbase, Redfin, Novo Nordisk
Check out the companies making headlines in premarket trading. Bank stocks — Shares of major banks were under pressure Monday as worries over a possible U.S. economic slowdown weighed on them. JPMorgan Chase dropped more than 1% along with Citigroup , Wells Fargo , Bank of America , Morgan Stanley and Goldman Sachs . DoorDash […]
Read More
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop 15.7% of their […]
Read More
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
Check out the companies making headlines in midday trading: Box — Shares declined more than 3% after the cloud storage company’s top-line guidance fell short of estimates. Box sees first-quarter revenue coming in between $274 million and $275 million, while analysts polled by LSEG expected $279.5 million. Box’s fourth-quarter revenue of $280 million exceeded Wall […]
Read More
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
Check out the companies making headlines in midday trading: Box — Shares declined more than 3% after the cloud storage company’s top-line guidance fell short of estimates. Box sees first-quarter revenue coming in between $274 million and $275 million, while analysts polled by LSEG expected $279.5 million. Box’s fourth-quarter revenue of $280 million exceeded Wall […]
Read More
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images Novo Nordisk on Wednesday said it will offer its weight loss drug Wegovy for less than half of its usual price per month through a new direct-to-consumer online pharmacy. The cash-pay offering is available to millions of patients […]
Read More
Amgen starts two critical late-stage trials for weight loss drug MariTide
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Wednesday said it has started two critical late-stage trials for its experimental weight loss injection MariTide, another step in its bid to enter the booming obesity drug market. “We’re delighted to share […]
Read More
Healthy Returns: AbbVie is the newest potential weight loss drug market player
A sign stands outside an Abbvie facility in Cambridge, Massachusetts. Brian Snyder | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The booming weight loss drug market has gained a new potential competitor. AbbVie […]
Read More